This paper is in the following e-collection/theme issue:

Immunology, Allergy, Rheumatology (91) Cost-Effectiveness and Economics (259) Substance Abuse (428)

Published on in Vol 11, No 2 (2022): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35300, first published .
Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

Authors of this article:

Geoff McCombe1 Author Orcid Image ;   Davina Swan1 Author Orcid Image ;   John S Lambert1, 2 Author Orcid Image ;   Eileen O’Connor1 Author Orcid Image ;   Zoe Ward3 Author Orcid Image ;   Peter Vickerman3 Author Orcid Image ;   Gordana Avramovic1, 2 Author Orcid Image ;   Des Crowley4 Author Orcid Image ;   Willard Tinago1 Author Orcid Image ;   Nyashadzaishe Mafirakureva3 Author Orcid Image ;   Walter Cullen1 Author Orcid Image
Article Authors Cited by (2) Tweetations (5) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.